Kiromic Biopharma Files Bankruptcy/Receivership 8-K
| Field | Detail |
|---|---|
| Company | Kiromic Biopharma, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: bankruptcy, receivership, financial-distress
Related Tickers: KRBP
TL;DR
Kiromic Biopharma is in bankruptcy/receivership as of March 21, 2025.
AI Summary
Kiromic Biopharma, Inc. filed an 8-K on March 21, 2025, reporting a bankruptcy or receivership event. The company, previously known as Kiromic, Inc., is incorporated in Delaware and has its principal executive offices in Houston, Texas.
Why It Matters
This filing indicates a significant financial distress event for Kiromic Biopharma, potentially impacting its operations, stock value, and stakeholders.
Risk Assessment
Risk Level: high — A bankruptcy or receivership filing is a severe indicator of financial distress and operational uncertainty.
Key Players & Entities
- Kiromic Biopharma, Inc. (company) — Registrant
- March 21, 2025 (date) — Date of earliest event reported
- Kiromic, Inc. (company) — Former company name
- 7707 Fannin, Suite 140 Houston, TX, 77054 (address) — Principal executive offices
FAQ
What specific type of bankruptcy or receivership is Kiromic Biopharma undergoing?
The filing indicates 'Bankruptcy or Receivership' as an item of disclosure but does not specify the chapter or exact nature of the proceedings within this 8-K.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated March 21, 2025.
What was Kiromic Biopharma's former company name?
The company's former name was Kiromic, Inc., with a name change occurring on October 29, 2019.
Where are Kiromic Biopharma's principal executive offices located?
The principal executive offices are located at 7707 Fannin, Suite 140, Houston, TX, 77054.
What is the SIC code for Kiromic Biopharma?
The Standard Industrial Classification (SIC) code for Kiromic Biopharma is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Kiromic Biopharma, Inc..